GlassScriptPhysician profile
Candace Jackson Moody
NPI 1619332152
$2,859.13
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,700 · 2022: $1,117 · 2023: $41.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $823.64 | 2021-2023 | |
| Amgen INC. | $403.95 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $180.49 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $171.27 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $158.22 | 2022 | |
| Jazz Pharmaceuticals INC. | $145.14 | 2021-2022 | |
| Biogen, INC. | $142.90 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $139.99 | 2021-2022 | |
| Eisai INC. | $118.21 | 2021-2022 | |
| Genzyme Corporation | $60.93 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $59.95 | 2021-2022 | |
| Neurelis, INC. | $55.53 | 2022 | |
| Upsher-Smith Laboratories LLC | $47.83 | 2021-2022 | |
| Lundbeck LLC | $46.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $46.19 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $44.21 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $44.10 | 2021 | |
| Celgene Corporation | $31.63 | 2022 | |
| Sk Life Science, INC. | $29.62 | 2022 | |
| Amneal Pharmaceuticals LLC | $26.63 | 2021 | |
| Neurocrine Biosciences, INC. | $18.71 | 2022 | |
| Emd Serono, INC. | $18.03 | 2022 | |
| Avion Pharmaceuticals | $16.39 | 2022 | |
| Lilly USA, LLC | $16.20 | 2021 | |
| Mdd US Operations, LLC | $13.16 | 2023 | Gocovri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.